1. Home
  2. LFMD vs GALT Comparison

LFMD vs GALT Comparison

Compare LFMD & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LifeMD Inc.

LFMD

LifeMD Inc.

HOLD

Current Price

$4.00

Market Cap

191.6M

Sector

Health Care

ML Signal

HOLD

Logo Galectin Therapeutics Inc.

GALT

Galectin Therapeutics Inc.

HOLD

Current Price

$2.86

Market Cap

199.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LFMD
GALT
Founded
1994
2000
Country
United States
United States
Employees
336
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
191.6M
199.2M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
LFMD
GALT
Price
$4.00
$2.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
3
Target Price
$9.14
$8.50
AVG Volume (30 Days)
1.2M
349.4K
Earning Date
03-09-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$17.76
N/A
Revenue Next Year
$17.66
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.60
$1.15
52 Week High
$15.34
$7.13

Technical Indicators

Market Signals
Indicator
LFMD
GALT
Relative Strength Index (RSI) 59.34 44.18
Support Level $3.43 $2.57
Resistance Level $4.20 $3.37
Average True Range (ATR) 0.35 0.24
MACD 0.06 -0.02
Stochastic Oscillator 60.81 27.38

Price Performance

Historical Comparison
LFMD
GALT

About LFMD LifeMD Inc.

LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Share on Social Networks: